BMED PHARMACEUTICALS established in 2017 and has taken its place in the Turkish pharmaceutical sector with the supply of medicines used in the treatment of rare diseases. BMED Pharmaceuticals, which cooperates with the world's leading companies, aims to ensure that its products and services are delivered to patients in the easiest, reliable and fastest manner within the framework of ethical and scientific values. Ophthalmology, Endocrinology, Urology, Hematology and Neurology branches, used in the treatment of rare diseases in the market has taken place. Headquartered in Ankara, BMED PHARMACEUTICALS has offices in Istanbul and Izmir. BMED is responsible for medicines used in the treatment of rare diseases in Turkey and carries out the sales and marketing with BMED own staff. BMED has distribution partners from more than 10 different countries, and 14 different partners of their medicines to ensure the attainment of the patients who need treatment in Turkey. BMED is constantly enriching its portfolio of medicines in the treatment of rare diseases in Turkey and continues its path towards the goal of becoming the largest pharmaceutical company in this area.